NF-κB activation in tumor cells can promotes tumor progression by enhancing their aggressive potential and increase the transcriptions of proinflammatory and angiogenetic genes, for example IL-12, TNF-α and iNOS [53]. The gene discussed is NFKB1; the disease is neoplasm.